Herbal medicinal product: MyrrhaArray, C: ongoing call for scientific data
Submitted by Anonymous (not verified) on 2 April 2024 - 10:46
Herbal medicinal product: MyrrhaArray, C: ongoing call for scientific data
Herbal medicinal product: Melissae foliumArray, C: ongoing call for scientific data
Submitted by Anonymous (not verified) on 2 April 2024 - 10:46
Herbal medicinal product: Melissae foliumArray, C: ongoing call for scientific data
List of signals discussed at PRAC since September 2012
Submitted by Anonymous (not verified) on 2 April 2024 - 10:13
List of signals discussed at PRAC since September 2012
Quarterly System Demo Q1 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2024, 09:00 (CET) to 26 March 2024, 13:30 (CET)
Submitted by Anonymous (not verified) on 27 March 2024 - 17:03
Quarterly System Demo Q1 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2024, 09:00 (CET) to 26 March 2024, 13:30 (CET)
Regulatory information – adjusted fees for applications to EMA from 1 April 2024
Submitted by Anonymous (not verified) on 27 March 2024 - 13:00
Regulatory information – adjusted fees for applications to EMA from 1 April 2024
Checklist for the submission of Type IA and Type IB (without linguistic review) product information annexes and Annex A (if applicable) - human
Submitted by Anonymous (not verified) on 27 March 2024 - 12:08
Checklist for the submission of Type IA and Type IB (without linguistic review) product information annexes and Annex A (if applicable) - human
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 27 March 2024 - 10:42
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 27 March 2024 - 10:41
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised
Submitted by Anonymous (not verified) on 27 March 2024 - 10:41
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 27 March 2024 - 10:39
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure